First Affiliated Hospital of Fujian Medical University clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
3 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 1 with a minor change only.
- Notable: 177Lu-P17-088 for mAPMR Prostate Cancer Primary endpoint(s) modified
- Notable: 225Ac-LNC1011 · Metastatic Castration-Resistant Prostate Cancer Phase changed: Phase 1/2 → Phase 2
- Minor: Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73 Trial completed
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-27 | NCT07898904 Incremental Value of Delayed 68Ga-DOTATATE PET/MR in the Detection of Liver Metastases | Recruiting | |
| 2026-10-26 | NCT07894315 EEG Feedback-Based Vagus Nerve Stimulation for Post-Stroke Dysphagia | Not Yet Recruiting |
Active trials by phase
| Early Phase 1 | 7 | |
| Phase 1 | 2 | |
| Phase 1/2 | 3 | |
| Phase 2 | 4 | |
| Phase 2/3 | 1 | |
| Phase 3 | 1 |
Not charted: 31 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 19
Prostate Cancer (10) · Dementia (2) · Hypertension (2) · Kidney Cancer (2) · Stroke (2) · ALS (1) · Bladder Cancer (1) · Cholangiocarcinoma (1) · Chronic Kidney Disease (1) · Diabetes (1)
Get alerts when First Affiliated Hospital of Fujian Medical University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.